Johnson & Johnson (JNJ)
271.19
+5.34
(+2.01%)
USD |
NYSE |
Sep 01, 16:00
273.12
+1.93
(+0.71%)
Pre-Market: 09:17
Johnson & Johnson Net Income (Annual) : 26.80B for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 26.80B |
| December 31, 2024 | 14.07B |
| December 31, 2023 | 13.33B |
| December 31, 2022 | 16.37B |
| December 31, 2021 | 20.88B |
| December 31, 2020 | 14.71B |
| December 31, 2019 | 15.12B |
| December 31, 2018 | 15.30B |
| December 31, 2017 | 1.30B |
| December 31, 2016 | 16.54B |
| December 31, 2015 | 15.41B |
| December 31, 2014 | 16.32B |
| December 31, 2013 | 13.83B |
| December 31, 2012 | 10.51B |
| December 31, 2011 | 9.672B |
| December 31, 2010 | 13.33B |
| December 31, 2009 | 12.27B |
| December 31, 2008 | 12.95B |
| December 31, 2007 | 10.58B |
| December 31, 2006 | 11.05B |
| December 31, 2005 | 10.41B |
| December 31, 2004 | 9.298B |
| December 31, 2003 | 7.197B |
| Date | Value |
|---|---|
| December 31, 2002 | 6.597B |
| December 31, 2001 | 5.668B |
| December 31, 2000 | 4.80B |
| December 31, 1999 | 4.167B |
| December 31, 1998 | 3.059B |
| December 31, 1997 | 3.303B |
| December 31, 1996 | 2.887B |
| December 31, 1995 | 2.403B |
| December 31, 1994 | 2.006B |
| December 31, 1993 | 1.787B |
| December 31, 1992 | 1.625B |
| December 31, 1991 | 1.461B |
| December 31, 1990 | 1.143B |
| December 31, 1989 | 1.082B |
| December 31, 1988 | 974.00M |
| December 31, 1987 | 833.00M |
| December 31, 1986 | 329.50M |
| December 31, 1985 | 613.70M |
| December 31, 1984 | 514.50M |
| December 31, 1983 | 489.00M |
| December 31, 1982 | 523.40M |
| December 31, 1981 | 467.60M |
| December 31, 1980 | 400.70M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Eli Lilly & Co. | 20.64B |
| Merck & Co., Inc. | 18.26B |
| Pfizer Inc. | 7.787B |
| Bristol Myers Squibb Co. | 7.056B |
| Liquidia Corp. | -68.92M |